GÜVEN, D. C. Et Al. 2022. HER2-low breast cancer could be associated with an increased risk of brain metastasis. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY , vol.27, no.2 , 332-339.

GÜVEN, D. C., KAYA, M. B., Fedai, B., ÖZDEN, M., YILDIRIM, H. Ç., KÖSEMEHMETOĞLU, K., ... KERTMEN, N.(2022). HER2-low breast cancer could be associated with an increased risk of brain metastasis. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY , vol.27, no.2, 332-339.

GÜVEN, DENİZ Et Al. "HER2-low breast cancer could be associated with an increased risk of brain metastasis," INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY , vol.27, no.2, 332-339, 2022

GÜVEN, DENİZ C. Et Al. "HER2-low breast cancer could be associated with an increased risk of brain metastasis." INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY , vol.27, no.2, pp.332-339, 2022

GÜVEN, D. C. Et Al. (2022) . "HER2-low breast cancer could be associated with an increased risk of brain metastasis." INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY , vol.27, no.2, pp.332-339.

@article{article, author={DENİZ CAN GÜVEN Et Al. }, title={HER2-low breast cancer could be associated with an increased risk of brain metastasis}, journal={INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY}, year=2022, pages={332-339} }